Horizon Aircraft Burns C$8.2M in Q1, Reiterates Going Concern Doubt
HOVR sits 37% above its 52-week low of $1.16.
Summary
Horizon Aircraft's Q1 FY2027 shows C$8.2M cash burn, C$70.1M remaining, and a reiterated going concern warning. R&D spending nearly tripled as the company builds its Cavorite X7 demonstrator. The company reported over US$1 billion in letters of intent for up to 200 aircraft purchases and 5 leases, and expects cash to fund operations for at least 24 months.
Updated with an SEC 8-K filing · What changed
Updates
· Reuters — Horizon Aircraft's Q1 adjusted loss per share was 6 cents, beating the 13-cent consensus estimate; revenue was zero.
· SEC 8-K — Horizon Aircraft's Cavorite X7 program is on track for initial testing in early calendar 2027, with the full-scale demonstrator expected by Q1 2027.
- Cavorite X7 Timeline — The Cavorite X7 program remains on track to begin initial testing in early calendar 2027. The full-scale demonstrator is expected to be completed by the first quarter of calendar 2027. Testing will include ground and taxi testing, followed by flight testing.
- Certification Progress — The company held several meetings with Transport Canada to design and build the full-scale demonstrator in a manner that supports progress toward certification.
- Strategic Partners — Strategic partners supporting Cavorite X7 development include BETA Technologies, Marshall Aerospace, RAMPF Composite Solutions, and North Aircraft Industries.
- Warrant Terms — Warrants (HOVRW) are exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share.
- R&D Spending — The company significantly increased research and development spending in relation to general and administrative spending to advance the Cavorite X7 program.
- Reporting Period — Financial and operational results are for the first quarter of fiscal 2027 ended August 31, 2026.
All 8 details
- Cavorite X7 program remains on track to begin initial testing in early calendar 2027.
- Full-scale Cavorite X7 demonstrator aircraft is expected to be completed by the first quarter of calendar 2027.
- Testing of the demonstrator will include ground and taxi testing, followed by flight testing.
- Company held several meetings with Transport Canada to design and build the full-scale demonstrator aircraft in a manner that supports progress toward certification.
- Strategic partners supporting Cavorite X7 development include BETA Technologies, Marshall Aerospace, RAMPF Composite Solutions, and North Aircraft Industries.
- Warrants (HOVRW) are exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share.
- The Company significantly increased research and development (R&D) spending in relation to general and administrative (G&A) spending to advance the Cavorite X7 program.
- Financial and operational results are for the first quarter of fiscal 2027 ended August 31, 2026.
Key Events · Earnings and Guidance · HOVR
-
New · · SEC 8-K
Letters of Intent Exceed US$1 Billion
Horizon Aircraft reported over US$1 billion in letters of intent for up to 200 aircraft purchases and 5 leases.
-
New · · SEC 8-K
Demonstrator Testing Plan Detailed
Testing of the demonstrator will include ground and taxi testing, followed by flight testing.
-
New · · SEC 8-K
Transport Canada Meetings Support Certification Path
The company held several meetings with Transport Canada to design and build the full-scale demonstrator aircraft in a manner that supports progress toward certification.
-
New · · SEC 8-K
Strategic Partners Named for Cavorite X7
Strategic partners supporting Cavorite X7 development include BETA Technologies, Marshall Aerospace, RAMPF Composite Solutions, and North Aircraft Industries.
-
New · · SEC 8-K
Warrant Terms Disclosed
Warrants (HOVRW) are exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share.
-
New · · SEC 8-K
R&D Spending Outpaces G&A
The company significantly increased research and development (R&D) spending in relation to general and administrative (G&A) spending to advance the Cavorite X7 program.
-
New · · SEC 8-K
Results Period Confirmed
Financial and operational results are for the first quarter of fiscal 2027 ended August 31, 2026.
-
Updated · · SEC 8-K
Going Concern Doubt Reiterated, Cash Runway Extended
Management states substantial doubt about the company's ability to continue as a going concern beyond the next 12 months without raising additional capital, despite C$70.1M in cash on hand. In October, the company said it expects cash to fund operations for at least 24 months.
-
Updated · · SEC 8-K
R&D Spending Nearly Triples, Cavorite X7 Timeline Set
Research and development expenses surged to C$7.4M from C$2.7M year-over-year, driven by engineering costs for the full-scale Cavorite X7 demonstrator aircraft. The Cavorite X7 program remains on track to begin initial testing in early calendar 2027, and the full-scale demonstrator is expected to be completed by the first quarter of calendar 2027.
-
Cash Burn Accelerates
Net cash used in operating activities was C$7.2M for the quarter, up from C$2.4M a year ago. Total cash declined C$8.2M to C$70.1M.
-
Warrant Remeasurement Masks Operating Loss
A C$3.8M non-cash gain from warrant liability remeasurement reduced the reported net loss to C$4.1M. Excluding this paper gain, the operating loss was C$9.1M.
Analysis · HOVR · Manufacturing
New Horizon Aircraft's Q1 FY2027 report shows the pre-revenue eVTOL developer consumed C$8.2 million in cash during the quarter, leaving C$70.1 million on hand. Management again flags substantial doubt about its ability to continue as a going concern beyond the next 12 months without raising additional capital. The quarter's headline net loss of C$4.1 million was flattered by a C$3.8 million non-cash gain from warrant liability remeasurement — a paper benefit driven by the falling share price, not operational improvement. R&D spending nearly tripled year-over-year to C$7.4 million as the company builds its full-scale Cavorite X7 demonstrator, which is the right strategic move but accelerates the cash burn. The company also fully exercised 4.57 million pre-funded warrants during the quarter, adding shares without meaningful new cash. In October, Horizon reported over US$1 billion in letters of intent for up to 200 aircraft purchases and 5 leases, and said it expects cash to fund operations for at least 24 months. The Cavorite X7 program remains on track to begin initial testing in early calendar 2027, with the full-scale demonstrator expected to be completed by the first quarter of calendar 2027.
How filings like this one have moved
In the 30 days to Oct 9, 2026, 36.7% of the 1061 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.62%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HOVR was trading at $1.59 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $102.7M. The 52-week trading range was $1.16 to $4.18. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.